ストックスクリーナーアプリを入手
10.87
0.00%
0.00
前日終値:
$10.87
開ける：
$10.87
24時間の取引高:
794
Relative Volume:
0.06
時価総額：
$263.89M
収益：
当期純損益:
$6.66M
株価収益率:
54.84
EPS:
0.1982
ネットキャッシュフロー:
$-379.20K
1週間 パフォーマンス:
+0.18%
1か月 パフォーマンス:
+0.28%
6か月 パフォーマンス:
+3.13%
1年 パフォーマンス:
+5.43%
1日の値動き範囲:
$10.87
$10.87
1週間の範囲:
$10.85
$10.87
52週間の値動き範囲:
$10.22
$10.89
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
名前
Drugs Made In America Acquisition Corp
セクター
電話
646-726-7074
住所
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs VYLR, DMII, EVAC, BCSS, CCXI
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.87 | 263.89M | 0 | 6.66M | -379.20K | 0.1982 |
VYLR
Vylor Inc.
|
72.18 | 48.17B | 0 | 0 | 0 | 0.00 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.18 | 648.47M | 0 | 8.58M | -1.11M | 0.134 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.31 | 602.60M | 0 | 12.80M | -714.00K | 0.2184 |
BCSS
Bain Capital Gss Investment Corp
|
10.21 | 596.26M | 0 | 8.29M | -686.50K | 0.142 |
CCXI
Churchill Capital Corp Xi
|
10.66 | 593.76M | 37.20M | -133.09M | -26.53M | 0.0647 |
Drugs Made In America Acquisition Corp (DMAA) 最新ニュース
Andretti Acquisition II (POLE) Stock Price, News & Analysis - Stock Titan
DMII 8-K & SEC Filings - Yahoo Finance Australia
Drugs Made In America Acquisition (DMAA) Stock Price, News & Analysis - Stock Titan
DMAA Stock Holds Near $10.89 as Acquisition Corp. Trades in Tight BandOutside Reversal - https://www.dars.gov.et/
DMIIU Holds Steady at $10.20 as Drugs Made In America Acquisition II Unit Trades FlatBreakout Stock Alerts - https://www.dars.gov.et/
HVMC Stock Price, Quote & News - Syfe
Drugs Made In America Restructures Merger with PAGC - The Globe and Mail
DMAA resets Power Analytics merger at $2.85B fixed valuation - Dealroom
Inside the $2.85B all-stock deal for DMAA (NASDAQ: DMAA) - Stock Titan
DMII 8-K & SEC Filings - Yahoo Finance Australia
EVOX Stock Price, Quote & News - Syfe
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer - The Manila Times
DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACGap Down Bounce Plays - dars.gov.et
DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACFund Manager Survey - dars.gov.et
DMAAR Rights Rise 8.43% to $0.13 on Renewed Interest in Drugs Made In America SPACLate Stage Breakouts - dars.gov.et
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeValue Area Low - dars.gov.et
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeQuality ETF - careplusvn.com
Drugs Made In America Acquisition II (DMII) Holds at $10.15 as SPAC Shares Trade Flat Within RangeETF Inflow Streak - www.dars.gov.et
Drugs Made In America Acquisition (NASDAQ:DMAA) Shares Down 0%Should You Sell? - MarketBeat
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingProfitability Factor - careplusvn.com
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionPCR Divergence - careplusvn.com
DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) logs $3.7M income as redemptions cut SPAC trust - Stock Titan
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeUp Down Ratio - dars.gov.et
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsDouble Top - Vinanet
DMAAR Rights Hold Flat at $0.15 as Range-Bound Trading PersistsIV Percentile - careplusvn.com
DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilitySystematic Flow - Vinanet
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAU - TradingView
Drugs Made In America Acquisition Corp. Revenue Breakdown – BOATS:DMAAR - TradingView
AstraZeneca falls to third-largest UK company amid US merger talks - theguardian.com
DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsVolume Oscillator - Vinanet
Drugs Made In America Acquisition Corp. Revenue Breakdown – NASDAQ:DMAAU - TradingView
PHAR Q2 2026 Earnings: Marginal EPS Miss Triggers 15.5% SelloffCFO Commentary Report - careplusvn.com
DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueDealer Positioning - vinanet.vn
DMAA Holds Steady at $10.71 as SPAC Continues Trading in Tight RangeSynthetic Short - vinanet.vn
Drugs Made In America Acquisition Corp (DMAA) 財務データ
収益
当期純利益
現金流量
EPS
0.47%
大文字化:
|
ボリューム (24 時間):